The ongoing phase 3 studies in China are expected to run through 2024 and 2025, providing further insights into its long-term benefits and safety
I was one of the VERY first patients
In the study, 31 patients with type 2 Diabetes received single subcutaneous injections of IcoSema, icodec, or semaglutide, with 69 weeks washout between doses
if confirmed, the medication should not be restarted) [1] You develop right-upper abdominal pain, jaundice (yellowing of skin/eyes), pale stools or dark urine (possible gallbladder disease) You develop chest pain, severe breathlessness, or signs of allergic reaction Joint pain follows trauma or injury with suspected fracture Your healthcare provider may undertake investigations including blood tests (inflammatory markers, rheumatoid factor, uric acid), X-rays, or referral to rheumatology if inflammatory arthritis is suspected